Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3039-3049

  Shen, F ^a   Chen, P D ^a   Walfield, A M ^a   Ye, J ^a   House, J ^b   Brown, F ^b   Wang, C Y ^a  

^a United Biomedical Inc   (United States)

^b PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Differential; FMDV; Peptide ELISA

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; PEPTIDE; RECOMBINANT PROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONVALESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; SWINE; VACCINATION;

ANIMALS; ANTIGENS, VIRAL; APHTHOVIRUS; CATTLE; CONVALESCENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FOOT-AND-MOUTH DISEASE; GUINEA PIGS; IMMUNODOMINANT EPITOPES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SHEEP; SWINE; VACCINATION; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 0033529677     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00148-6     Document Type: Article

References (22)

1. Newman J.F.E., Piatti P.G., Gorman B.M., Burrage T.G., Ryan M.D., Flint M., Brown F. Foot-and-mouth disease virus particles contain replicase protein 3D. Proc Natl Acad Sci USA. 91:1994;733-737.
2. Pinto A.A., Garland J.M. Immune response to virus-infection-associated (VIA) antigen in cattle repeatably vaccinated with foot-and-mouth disease virus inactivated by formalin or acetylethyleneimine. J Hyg, Camb. 82:1979;41-50.
3. Neitzert E., Beck E., de Mello Augé P., Gomes I., Bergmann I.E. Expression of the aphthovirus RNA polymerase gene in Escherichia coli and its use together with other bioengineered nonstructural antigens in detection of late persistent infections. Virology. 184:1991;799-804.
4. Bergmann I.E., de Mello Augé P., Neitzert E., Beck E., Gomes I. Diagnosis of persistent aphthovirus infection and its differentiation from vaccination response in cattle by use of enzyme-linked immunoelectrotransfer blot analysis with bioengineered nonstructural viral antigens. Am J Vet Res. 54:1993;825-831.
5. Rodriguez A., Dopazo J., Sáiz J.C., Sobrino F. lmmunogenicity of nonstructural proteins of foot-and-mouth disease virus: differences between infected and vaccinated mice. Arch Virol. 136:1994;123-131.
6. Silberstein E., Kaplan G., Taboga 0., Duffy S., Palma E. Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch Virol. 142:1997;795-805.
7. Mackay D.K.J., Forsyth M.A., Davies P.R., Berlinzani A., Belsham G.J., Flint M., Ryan M.D. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, nonstructural proteins in ELISA. Vaccine. 16:1998;446-459.
8. Meyer R.F., Babcock G.D., Newman J.F.E., Burrage T.G., Toohey K., Lubroth J., Brown F. Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. J Virol Methods. 65:1997;33-43.
9. Lubroth J., Brown F. Identification of native foot-and-mouth disease virus nonstructural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci. 59:1995;70-78.
10. Sorensen K.J., Madsen K.G., Madsen E.S., Salt J.S., Nqindi J., Mackay D.K. Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the nonstructural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus. Arch Virol. 143:1998;1461-1476.
11. Wang C.Y. Synthetic-peptide-based immunodiagnosis of retrovirus infections: Current status and future prospects. Mizrahi A. Synthetic peptides in biotechnology, advances in biotechnological processes. vol. 10:1988;131-148.
12. Hosein B., Fang C.T., Popovsky M.A., Ye J., Zhang M., Wang C.Y. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci USA. 88:1991;3647-3651.
13. Mackay D.K.J., Forsyth M.A., Davies P.R., Salt J.S. Antibody to the nonstructural proteins of foot-and-mouth disease virus in vaccinated animals exposed to infection. Veterinary Quarterly. 20:(Suppl 2):1998;S9-S11.
14. Dekker A., Gijsen E. The possible use of native foot-and-mouth disease non-structural protein 3A in a serological screening test. Veterinary Quarterly. 20:(Suppl 2):1998;S27-S28.
15. Geysen M.H., Meleon R.H., Barteling S.J. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA. 81:1984;3998-4002.
16. Meloen R.H., Puyk W.C., Meijer D.J.A. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus. J Gen Virol. 68:(pt 2):1987;305-314.
17. Meloen R.H., Amerongen A.V., Hage-Van Noort M., Langedijk J.P., Posthumus W.P., Puyk W.C., Plasman H., Lenstra J.A., Langeveld J.P. The use of peptides to reconstruct conformational determinants; a brief review. Ann Biol Clin (Paris). 49:1991;231-241.
18. Wang J.J.G., Steel S., Wisniewolski R., Wang C.Y. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp4l envelope protein. Proc Natl Acad Sci USA. 83:1986;6159-6163.
19. Khabbaz R.F., Onarato I.M., Cannon R.O., Hartley T.M., Roberts B., Hosein B., Kaplan J.E. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 326:1992;375-380.
20. Wang C.Y., Wang J.J.G. Peptide composition and method for the detection of antibodies to HTLV-III. 1989;. US Patent 4,879,212.
21. Wang C.Y. Synthetic peptides specific for the detection of antibodies to HCV. 1992;. US Patent 5,106,726.
22. Wang C.Y., Wang J.J.G., Walters W.W. Peptide composition as antigen for detection of antibodies to HTLV-1, as a vaccine for ATL and methods therefor. 1989;. US Patent 4,833,071.